Birdwatch Note Rating
2024-11-29 00:53:01 UTC - HELPFUL
Rated by Participant: 87862316201459CCE48B6F17413B86E3A1ADA24CD99D30D6D7BE90164C8A678A
Participant Details
Original Note:
The new rule proposal does not mandate Ozempic as an obesity treatment. The proposed rule changes a decades-old Medicare rule that prohibits the program from covering weight loss drugs. This makes Ozempic and other semaglutides available to those covered by Medicare. https://apnews.com/article/ozempic-biden-rfk-jr-trump-antiobesity-drugs-caaa2f888435af1d32bedb83e9ddbc0a
All Note Details